UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033132
Receipt number R000037785
Scientific Title Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.
Date of disclosure of the study information 2018/06/25
Last modified on 2020/11/23 12:59:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.

Acronym

SBRT for non-spine bone mets.

Scientific Title

Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.

Scientific Title:Acronym

SBRT for non-spine bone mets.

Region

Japan


Condition

Condition

non-spine bone metastases

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate prospectively the palliative efficacy of SBRT for painful non-spine bone metastases.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain-progression free rate at 6 months

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

SBRT of 35 Gy in 5 fractions for painful non-spine bone metastases

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. pathological or clinical diagnosis of non-spine bone metastases
2. painful non-spine metastases with NRPS of 2 or more
3. An hour resting in supine is possible
4. Age; 20-
5. Expected prognosis; 6 months or more
6. Written informed consent

Key exclusion criteria

1. The lesion is skull base bone
2. The lesion is radiosensitive tumor
3. Radiation history in the same area with 3 months
4. Serious medical or psychological problems

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Katsuyuki Karasawa

Organization

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Division name

Radiation Oncology

Zip code


Address

3-18-22 Honkomagome, Bunkyo-ku,Tokyo

TEL

03-3823-2101

Email

karasawa@cick.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kei Ito

Organization

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Division name

Radiation Oncology

Zip code


Address

3-18-22 Honkomagome, Bunkyo-ku,Tokyo

TEL

03-3823-2101

Homepage URL

http://www.cick.jp/houshasenchiryou/

Email

keiito@cick.jp


Sponsor or person

Institute

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 05 Month 15 Day

Date of IRB

2018 Year 06 Month 25 Day

Anticipated trial start date

2018 Year 06 Month 25 Day

Last follow-up date

2019 Year 12 Month 20 Day

Date of closure to data entry

2020 Year 01 Month 15 Day

Date trial data considered complete

2020 Year 01 Month 15 Day

Date analysis concluded

2020 Year 01 Month 20 Day


Other

Other related information



Management information

Registered date

2018 Year 06 Month 25 Day

Last modified on

2020 Year 11 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037785


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name